Overview
- The film opened in early October and posted roughly $8 million in its North American debut with a worldwide total that industry trackers place in the low‑tens of millions, while audiences gave it a C+ CinemaScore and critics’ aggregates settled in the low‑50s.
- Trade reporting cites widely varying cost estimates with production figures commonly near $125 million, marketing around $100 million, and break‑even targets often placed near $300–350 million.
- At least one outlet has reported a projected theatrical loss as large as $250 million based on the weak box office and the contested production and marketing totals.
- Exhibitors sharply reduced premium‑format bookings for the title and IMAX runs were pulled after a short stay, and Warner Bros. shifted post‑release advertising to a “decide for yourself” message to try to broaden interest.
- The movie’s poor international holds, including a weak 10‑day run in India, have compounded the shortfall and prompted studio executives to signal a reevaluation of big‑budget, auteur‑led gambles going forward.